More sleep, veggies, and movement to reduce risk for a hypertensive disorder of pregnancy
The nuMom2b study – short for “Nulliparous* Pregnancy Outcomes Study: Monitoring Mothers-To-Be” – is a prospective study that enrolled over 10,000 first time pregnant women across the United States and followed them through their pregnancies and after delivery. In this study, researchers used the wellness data collected in nuMom2b to study how wellness related to risk for a hypertensive disorder of pregnancy (HDP). Wellness data included information about their nutrition, exercise, illnesses, and sleep. The study results showed that patients reporting higher vegetable consumption in the first trimester, as well as more exercise in the second and third trimesters had decreased risk for an HDP. Also more sleep combined with exercise in the third trimester also decreased HDP risk. Identifying the healthful behaviors that lower the risk for a hypertensive disorder of pregnancy can help develop recommendations and prevention programs to support lowering pregnant women’s risk for developing an HDP.
*Nulliparous = a female of reproductive age who has never had a live delivery
Link: https://pubmed.ncbi.nlm.nih.gov/36959650/
Citation: Mollard E, Cottrell C. Lifestyle and the hypertensive disorders of pregnancy in nulliparous women in the United States: a secondary data analysis of the nuMom2b. BMC Pregnancy Childbirth. 2023 Mar 23;23(1):201. doi: 10.1186/s12884-023-05522-8. PMID: 36959650; PMCID: PMC10035211.
About Research Roundup
Each quarter, our team of science writers reviews the most current research studies related to hypertensive disorders of pregnancy and summarizes those studies of greatest interest and potential impact to our community, including research studies related to risk assessment, diagnosis, prevention, and treatment. Special thanks to our volunteer research team, who under the leadership of Dr. Elizabeth Sutton, make Research Roundup possible and to our Patient Advisory Council, who reviews these materials from the patient perspective.
Related Articles
Your story is needed to improve outcomes for moms like you. Add your voice to critical preeclampsia research to ensure that every story is heard.
Frequently asked questions about the Preeclampsia Registry, a patient-driven registry and biobank.
The Preeclampsia Foundation offers research funding, study recruitment, and other patient engagement services to researchers.
We provide research grant funding to advance progress towards detection, prevention, or treatment of preeclampsia, HELLP syndrome, and other hypertensive disorders of pregnancy.
While the foundations of preeclampsia are believed to develop in the early stages of pregnancy, the current screening process occurs at 20 weeks, nearly half way through the second trimester. When cli...
Research suggests that preeclampsia may develop in a two-stage process. The first stage involves challenges to the way that the placenta implants and grows. In a normal pregnancy, a type of placental...
The risk of developing hypertension and cardiovascular disease (CVD) significantly increases for patients who experience gestational hypertension, preeclampsia, or other hypertensive disorders of preg...
Cerebral complications from preeclampsia and eclampsia are a major cause of maternal mortality and long-term neurological impact. Understanding pathophysiology (changes in how the body works as a resu...
A new research study suggests that blood pressure changes during the first 20 weeks of pregnancy—called blood pressure trajectories—may give providers a peek at a woman’s risk of dev...